Justia Securities Law Opinion Summaries

A publicly traded Delaware company specializing in plant-based sweeteners became the subject of a merger transaction led by the controlling stockholder of a major suitor, who was also the father of the company’s CEO. Shortly after becoming interim CEO, the son secretly provided his father’s investment firm with confidential and material nonpublic financial information, including a key valuation report. Over the next several months, the CEO continued to share sensitive company data with his father’s entities. The father’s investment firm then accumulated a significant ownership stake in the company and submitted an offer to acquire it. The board responded by forming a Special Committee and attempting to restrict the CEO’s involvement, but after he refused to sign a confidentiality agreement, he was placed on leave. Despite this, he was later given access to confidential board materials and attended meetings regarding the sale process.The Court of Chancery of the State of Delaware reviewed the case after the plaintiff, a stockholder, brought a class action challenging the merger and related conduct. The plaintiff alleged breaches of fiduciary duty, statutory violations under 8 Del. C. § 203, and conversion. The defendants moved to dismiss the complaint under Rule 12(b)(6). The court found that the plaintiff had adequately alleged that the board’s process was grossly negligent, noting the board’s failure to adequately wall off the conflicted CEO and its misleading proxy statement to stockholders. As a result, the statutory safe harbors under 8 Del. C. § 144(a)(1) and (a)(2) were unavailable at the pleading stage.The court held that claims could proceed against the CEO and the executive chairman, who had negotiated a lucrative consulting agreement in connection with the merger. It dismissed the remaining directors, finding them disinterested and not alleged to have acted in bad faith. The court also dismissed the statutory and conversion claims, holding that the challenged stockholder vote satisfied Section 203’s requirements and that deficiencies in the proxy statement did not render the merger invalid. View "Dodiya v. Franklin" on Justia Law

Roy Hill, founder and CEO of Clean Energy Technology Association, Inc. (CETA), solicited investments by representing that CETA owned patented carbon capture technology and promised investors returns from these assets. CETA, however, operated as a Ponzi scheme, using funds from new investors to pay returns to earlier ones. UniBank, a Washington-based commercial bank, provided secured loans to investors who used the funds to buy interests in CETA’s purported assets. UniBank perfected its security interests in the distributions from CETA. After the SEC initiated an enforcement action alleging fraud and sought appointment of a receiver, Albert Black was appointed to marshal CETA’s assets for the benefit of creditors and investors.In parallel litigation, investors sued UniBank in Washington state court for fraud and negligence, but UniBank obtained summary judgment on the basis that it owed no duty to the investors. Meanwhile, in the United States District Court for the Western District of Texas, the receiver recommended a pro rata distribution of the remaining CETA estate funds to all investors and creditors based on net cash losses, aggregating UniBank’s claims with those of other victims rather than honoring UniBank’s asserted secured creditor priority. UniBank objected, arguing its perfected liens should grant it priority recovery. The district court overruled UniBank’s objection, adopted the receiver’s recommendation, and ordered pro rata distributions.On appeal, the United States Court of Appeals for the Fifth Circuit reviewed the district court’s order. The Fifth Circuit held that the district court failed to provide UniBank with adequate due process because it adopted the receiver’s recommendation with only a cursory analysis and without giving UniBank a meaningful opportunity to present its evidence and arguments, particularly given the extensive record. The court vacated the district court’s order and remanded for further proceedings consistent with due process requirements, without expressing a view on the merits. View "Black v. Unibank" on Justia Law

A large public pension fund alleged that a government-sponsored enterprise and three of its senior officers made false and misleading statements regarding the company’s exposure to subprime and Alt-A mortgages during a period preceding the 2008 financial crisis. The pension fund claimed that the company’s public statements and disclosures understated its exposure to high-risk loans, while internal documents and risk assessments suggested a much greater level of risk. It further argued that, when the company’s actual exposure came to light, its stock price fell, resulting in significant losses to shareholders.Previously, the United States District Court for the Northern District of Ohio denied class certification, excluded the pension fund’s expert, and granted summary judgment to the defendants. The court concluded that the pension fund failed to establish reliance due to an inability to show that the company’s stock traded in an efficient market, improperly rejected the fund’s price-maintenance theory of fraud, found insufficient evidence to support loss causation and damages, and determined the defendants did not act with scienter. The court also found no actionable misstatements regarding credit-risk and underwriting standards, and dismissed control-person liability claims after finding no underlying securities violation.On appeal, the United States Court of Appeals for the Sixth Circuit reversed in part, vacated in part, and remanded. The appellate court held that the pension fund presented sufficient evidence for a jury to find that the company made materially false or misleading statements regarding its subprime and Alt-A exposure, and that issues of scienter and reliance were present. The court determined that the lower court erred in rejecting the price-maintenance theory and improperly excluded the plaintiff’s expert. It also concluded that the fund should be allowed another opportunity to seek class certification and to present evidence of loss causation and damages. The court reinstated the underlying securities fraud and control-person liability claims for further proceedings. View "OPERS v. FHLMC" on Justia Law

Plaintiffs, who were investors in a pharmaceutical company, brought a putative class action alleging securities fraud. The company had developed a drug to treat geographic atrophy, a form of age-related macular degeneration, and conducted two large clinical trials (OAKS and DERBY) before the drug's approval by the FDA. During the class period, company representatives publicly stated that there were no observed cases of retinal vasculitis, a serious eye condition, among trial participants. After the drug's commercialization, new reports emerged of retinal vasculitis in patients treated with the drug, leading to a decline in the company’s stock price and the addition of a warning to the drug’s label.The action was initially filed in the U.S. District Court for the District of Delaware and later transferred to the U.S. District Court for the District of Massachusetts. The plaintiffs argued that the company's statements were misleading half-truths because the clinical trials were not specifically designed to detect retinal vasculitis, and this limitation was not disclosed to investors. The defendants moved to dismiss, contending that the statements were not materially misleading and that there was no sufficient allegation of scienter (intent to defraud). The U.S. District Court for the District of Massachusetts granted the motion, holding that the omissions were not actionable because the relevant trial protocols and methodologies had been publicly disclosed and disagreements over scientific methodology do not support securities fraud claims.On appeal, the United States Court of Appeals for the First Circuit affirmed the dismissal. The court held that the company’s statements were not materially misleading because the information regarding the trial protocols, including when and how retinal vasculitis could be detected, was publicly available. The court concluded that no material misrepresentation or actionable omission had occurred, and thus affirmed the district court’s judgment. View "In Re: Apellis Pharm., Inc. Securities Litigation" on Justia Law

A German national was named as a relief defendant in a civil enforcement action brought by the Securities and Exchange Commission. The SEC alleged that he received approximately $3.3 million in funds, transferred from U.S.-based companies controlled by his son, who was a primary defendant in a securities fraud scheme. The SEC sought to recover those funds through disgorgement, claiming the money represented proceeds of illegal activity. The relief defendant maintained that he lived in Germany, had limited visits to the United States, and challenged the court's personal jurisdiction over him.The United States District Court for the District of Massachusetts initially denied the relief defendant’s motion to dismiss for lack of personal jurisdiction and later imposed sanctions against him for discovery violations. The court entered summary judgment for the SEC, ordering disgorgement. On appeal, the United States Court of Appeals for the First Circuit concluded in a prior decision that the district court could not establish personal jurisdiction over him by imputing the contacts of his son, and remanded for further proceedings.On remand, the district court permitted the SEC to seek jurisdictional discovery regarding the relief defendant’s own contacts with the United States. The relief defendant did not oppose discovery, refused to participate further, and failed to communicate directly with the court. The district court sanctioned him by deeming facts establishing personal jurisdiction as admitted, and reinstated summary judgment for the full disgorgement amount.The United States Court of Appeals for the First Circuit held that the relief defendant forfeited or waived any challenge to the jurisdictional discovery process, the district court’s orders, and related arguments by failing to raise them in the district court after remand. The court affirmed the district court’s judgment. View "SEC v. Gastauer" on Justia Law

A Swedish government agency managing a public pension fund initiated a consolidated class action for securities fraud under Section 10(b) of the Securities Exchange Act of 1934 and SEC Rule 10b-5. The claims were brought against a third-party auditor and several former executives of a New York-based, federally insured commercial bank, which collapsed in 2023 after significant losses tied to a shift into cryptocurrency banking. The plaintiff alleged that the auditor and executives made false statements regarding the bank’s liquidity and risk management, leading to artificial inflation of the bank’s stock price and subsequent investor losses when the bank failed.After the bank’s collapse, the Federal Deposit Insurance Corporation (FDIC) was appointed as receiver. The FDIC intervened in the case and moved to dismiss, arguing that, under the Succession Clause of the Financial Institutions Reform, Recovery, and Enforcement Act of 1989 (FIRREA), it had succeeded to all rights of the bank’s stockholders regarding the institution and its assets, thus “owning” the securities fraud claims. The United States District Court for the Eastern District of New York agreed and dismissed the complaint for lack of prudential standing, concluding that the claims had transferred to the FDIC and that the plaintiff had not exhausted required administrative remedies.On appeal, the United States Court of Appeals for the Second Circuit reviewed the statutory interpretation of the Succession Clause. The court held that the Clause does not transfer to the FDIC individual securities fraud claims brought under Section 10(b) and Rule 10b-5, as these are not rights held by stockholders in their capacity as such, but rather as purchasers of securities. Additionally, the court found that administrative exhaustion was not required, as the claims were not against the failed bank or the FDIC as receiver. The Second Circuit vacated the district court’s judgment and remanded the case for further proceedings. View "Fonden v. FDIC" on Justia Law

Bradley Stinn, a former chief executive officer of a large jewelry retailer, was convicted in 2009 of securities fraud, mail fraud, and conspiracy. The charges stemmed from a scheme in which Stinn and others allegedly concealed the substantial risk of customer defaults in the company’s credit-extension program, thereby fraudulently inflating the company’s financial reports. As a result, Stinn received a significant bonus and salary increase that were tied to the company’s reported earnings. The company ultimately went bankrupt, and Stinn served a sentence of imprisonment and supervised release.The United States District Court for the Eastern District of New York presided over Stinn’s trial, where the jury was instructed it could convict under either a traditional fraud theory or the now-invalidated right-to-control theory. The jury returned a general verdict of guilty, and Stinn unsuccessfully challenged his conviction on direct appeal and in a habeas petition. After the Supreme Court in Ciminelli v. United States rejected the right-to-control theory, Stinn filed a petition for a writ of error coram nobis, seeking to vacate his conviction on the grounds that the jury may have relied on an invalid theory. The district court denied the petition, holding that any error was harmless because sufficient evidence supported the conviction under the traditional fraud theory.On appeal, the United States Court of Appeals for the Second Circuit affirmed the district court’s judgment. The Second Circuit held that the standard for harmless error in coram nobis proceedings is that articulated in Kotteakos v. United States, which requires a petitioner to show that the error had a substantial and injurious effect on the verdict. The court found that Stinn failed to meet this burden, as the evidence overwhelmingly supported conviction under the traditional fraud theory. Thus, the denial of coram nobis relief was affirmed. View "Stinn v. United States of America" on Justia Law

The plaintiffs, who purchased securities issued by an animal health company, brought a proposed class action against the company and certain officers and directors. They alleged that the company misled investors by publicly attributing its sales growth to strong end-user demand, when in reality, the growth was artificially created through “channel stuffing”—the practice of pushing excessive inventory onto distributors, thus inflating reported revenues. The company’s alleged conduct took place around the time of major acquisitions and included public statements and SEC filings that, according to the plaintiffs, failed to disclose the channel stuffing and misrepresented the true basis for revenue increases.The United States District Court for the Southern District of Indiana reviewed the plaintiffs’ first amended complaint and dismissed it without prejudice for failure to state a claim, allowing an opportunity to amend. The plaintiffs sought to file a second amended complaint, asserting claims under the Securities Exchange Act of 1934 and the Securities Act of 1933, as well as related “control person” liability provisions. The district court denied leave to amend, deeming further amendment futile, and dismissed the case with prejudice. The court concluded the plaintiffs had not adequately alleged actionable misstatements, scienter (intent to defraud), or loss causation under the heightened pleading standards required by the Private Securities Litigation Reform Act and Federal Rule of Civil Procedure 9(b).On appeal, the United States Court of Appeals for the Seventh Circuit affirmed the district court’s decision. The appellate court held that, even assuming the statements at issue could be considered materially misleading, the plaintiffs failed to allege facts giving rise to a strong inference of scienter. The court also agreed that the claims under the Securities Act sounded in fraud and therefore required particularized pleading, which the plaintiffs had not met. Consequently, all claims were properly dismissed with prejudice. View "Hunter v Elanco Animal Health Incorporated" on Justia Law

A healthcare technology company formed in 2016 included the appellant as a founding member. The company’s operating agreement was modified several times, and in August 2020, the appellant assigned his membership interest to another member and a separate entity, ceasing to receive further distributions. Two years later, the appellant, through counsel, alleged that the assignment was executed under duress and fraud, and that there were improprieties with the amended operating agreements. In February 2024, the appellant, joined initially by another individual, filed suit against several members and the company, alleging negligent misrepresentation, securities violations, interference with contractual relations, conspiracy, conversion, and breach of fiduciary duty.The Harrison County Circuit Court, upon motion from the defendants, granted summary judgment, determining that all of the appellant’s claims were barred by Mississippi’s three-year statute of limitations. The court held that the appellant’s injury accrued at the time of the assignment in August 2020, and that the complaint filed in February 2024 was untimely. Arguments regarding forgery of an earlier operating agreement were found irrelevant to the assignment. Subsequent efforts by the appellant to supplement the appellate record with new evidence were denied after a limited remand from the Supreme Court of Mississippi.On appeal, the Supreme Court of Mississippi reviewed only the appellant’s arguments concerning the denial of record supplementation, as he failed to challenge the grant of summary judgment in his primary brief. The Court held that issues not raised in the appellant’s initial brief are waived, and the pro se status of the appellant did not excuse this failure. The Court also found no abuse of discretion in denying the request to supplement the record. Accordingly, the Supreme Court of Mississippi affirmed the trial court’s grant of summary judgment. View "Johnson v. Nichols" on Justia Law

The petitioner, a former project manager at a large corporation, raised internal compliance concerns in 2018. In April 2019, he was notified that he would be subject to a reduction in force and laid off, effective June 21, 2019. He subsequently filed several internal complaints alleging that his layoff and the company’s refusal to rehire him for numerous positions were retaliatory acts in response to his whistleblowing. After his layoff, he was placed on short-term disability and given a period during which he could apply for other positions within the company, but his applications were unsuccessful.Following these events, the petitioner filed a whistleblower-retaliation complaint under the Sarbanes–Oxley Act (SOX) with the Occupational Safety and Health Administration in December 2020. OSHA dismissed the complaint as untimely. The petitioner then sought review before an administrative law judge (ALJ), who held a hearing and dismissed the claims as untimely, also finding that equitable tolling was not warranted. The petitioner appealed, and the Administrative Review Board (ARB) affirmed the ALJ’s dismissal.On review, the United States Court of Appeals for the Second Circuit determined that the ARB did not err in finding the claims untimely. The court held that the SOX 180-day filing window begins when the employee is notified of the adverse action or when the refusal to rehire becomes apparent, not the last date of employment or the date of final application rejection. The court also found no basis for equitable tolling, as the petitioner knew or should have known of the alleged retaliation well before the statutory deadline. Accordingly, the Second Circuit denied the petition for review. View "Mehrotra v. U.S. Dep't of Lab." on Justia Law